$IVFH

INNOVATIVE FOOD HOLDINGS INC

CIK:0000312257|SEC Filings

Consolidated Statements of Operations - USD ($)	3 Months Ended		6 Months Ended
Consolidated Statements of Operations - USD ($)	Jun. 30, 2026	Jun. 30, 2025	Jun. 30, 2026	Jun. 30, 2025
Income Statement [Abstract]
Revenue	$ 13,057,122	$ 16,637,690	$ 25,233,695	$ 31,663,705
Cost of goods sold	9,638,652	12,358,878	18,692,604	23,464,629
Gross margin	3,418,470	4,278,812	6,541,091	8,199,076
Selling, general and administrative expenses	3,023,457	3,452,242	5,795,385	7,112,050
Total operating expenses	3,023,457	3,452,242	5,795,385	7,112,050
Operating income	395,013	826,570	745,706	1,087,026
Other income (expense):
Interest income (expense), net	(630)	(1,014)	(7,932)	(7,651)
Total other income (expense)	(630)	(1,014)	(7,932)	(7,651)
Net income before taxes	394,383	825,556	737,774	1,079,375
Income tax expense	28,391	0	28,391	0
Net income from continuing operations	365,992	825,556	709,383	1,079,375
Net income (loss) from discontinued operations	(1,608)	(767,046)	1,495,277	(1,451,301)
Consolidated net income (loss)	$ 364,384	$ 58,510	$ 2,204,660	$ (371,926)
Net income per share from continuing operations - basic (in Dollars per share)	$ 0.007	$ 0.015	$ 0.013	$ 0.02
Net income per share from continuing operations - diluted (in Dollars per share)	0.007	0.015	0.013	0.02
Net income (loss) per share from discontinued operations - basic (in Dollars per share)	0	(0.014)	0.027	(0.027)
Net income (loss) per share from discontinued operations - diluted (in Dollars per share)	$ 0	$ (0.014)	$ 0.027	$ (0.027)
Weighted average shares outstanding - basic (in Shares)	54,649,479	54,785,684	54,649,479	54,376,253
Weighted average shares outstanding - diluted (in Shares)	54,649,479	54,785,684	54,649,479	54,376,253

Consolidated Statements of Cash Flows - USD ($)	3 Months Ended		6 Months Ended		12 Months Ended
Consolidated Statements of Cash Flows - USD ($)	Jun. 30, 2026	Jun. 30, 2025	Jun. 30, 2026	Jun. 30, 2025	Dec. 31, 2025
Cash flows from operating activities:
Net income (loss)	$ 364,384	$ 58,510	$ 2,204,660	$ (371,926)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Gain on sale of assets			(2,685,277)	0
Loss on early extinguishment of debt			608,539	0
Depreciation and amortization			141,902	218,474
Amortization of right of use asset	70,078	61,469	138,973	123,972
Amortization of discount on notes payable			0	2,568
Stock based compensation			47,748	202,402
Change in value of stock appreciation rights			(16,143)	(227,263)
Provision for credit losses	7,331	755	15,530	28,310
Changes in assets and liabilities:
Accounts receivable, net			179,316	2,094,325
Inventory, net			580,568	389,479
Other current assets			80,638	(99,711)
Accounts payable and accrued liabilities			(700,498)	(2,473,041)
Accrued separation costs - related parties			(83,860)	(166,665)
Deferred revenue			0	(3,800)
Operating lease liability			(136,864)	(119,411)
Net cash used in operating activities			375,232	(402,287)
Cash flows from investing activities:
Cash received from sale of land and building, net of costs			8,782,365	0
Cash paid for purchase of property and equipment			(31,183)	(208,886)
Cash received from disposition of asset			10,000	0
Net cash provided by (used in) investing activities			8,761,182	(208,886)
Cash flows from financing activities:
Payments on debt			(8,809,669)	(88,654)
Payments on financing leases			(6,189)	(126,813)
Borrowings from line of credit			0	500,000
Payments on line of credit			0	(500,000)
Net cash used in financing activities			(8,815,858)	(215,467)
Decrease in cash and cash equivalents, and restricted cash			320,556	(826,640)
Cash and cash equivalents, and restricted cash at beginning of period			1,520,012	2,380,195	$ 2,380,195
Cash and cash equivalents, and restricted cash at end of period - continuing operations	1,820,127	1,520,335	1,820,127	1,520,335
Cash and cash equivalents, and restricted cash at end of period - discontinued operations	20,441	33,220	20,441	33,220
Cash and cash equivalents, and restricted cash at end of period	$ 1,840,568	$ 1,553,555	1,840,568	1,553,555	$ 1,520,012
Cash paid during the period for:
Interest			197,138	409,271
Taxes			28,391	0
Non-cash investing and financing activities:
Issuance of common stock under compensation plans			0	74
Issuance of common stock from common stock to be issued			0	37
Issuance of stock for cashless exercise of options			0	8
Capitalized interest on financing lease			$ 0	$ 1,130

Consolidated Balance Sheets - USD ($)	Jun. 30, 2026	Dec. 31, 2025
Current assets
Cash and cash equivalents	$ 1,820,127	$ 927,468
Cash, restricted	0	507,517
Accounts receivable, net	5,301,528	5,300,190
Inventory, net	2,893,036	3,473,604
Other current assets	63,505	144,143
Asset held for sale - discontinued operations	0	6,144,793
Current assets - discontinued operations	20,929	281,699
Total current assets	10,099,125	16,779,414
Property and equipment, net	1,214,231	1,273,310
Right of use assets - operating leases, net	373,416	512,389
Right of use assets - finance leases, net	16,155	205,340
Amortizable intangible assets, net	294,902	338,059
Indefinite-lived intangible assets	217,000	217,000
Other noncurrent assets	40,000	40,000
Noncurrent assets - discontinued operations	0	215,509
Total assets	12,254,829	19,581,021
Current liabilities
Accounts payable	2,013,048	2,456,429
Accrued payroll	219,120	79,559
Accrued liabilities	446,440	499,811
Accrued separation costs - related parties, current portion	425,376	109,236
Stock appreciation rights liability	0	16,143
Notes payable, current portion	68,032	66,026
Lease liability - operating leases, current	302,620	285,534
Lease liability - finance leases, current	0	48,866
Current liabilities - discontinued operations	27,330	8,877,624
Total current liabilities	3,501,966	12,439,228
Note payable non-current	182,242	216,947
Accrued separation costs - related parties, non-current	0	400,000
Lease liability - operating leases, non-current	81,013	234,963
Lease liability - finance leases, non-current	0	52,683
Total liabilities	3,765,221	13,343,821
Commitments & contingencies (see note 18)	0	0
Stockholders’ equity
Common stock: $0.0001 par value; 500,000,000 shares authorized; 57,493,776 shares issued, and 54,649,479 shares outstanding at June 30, 2026 and December 31, 2025, respectively	5,746	5,746
Additional paid-in capital	45,695,650	45,647,902
Treasury stock: 2,644,297 shares outstanding at June 30, 2026 and December 31, 2025	(1,141,372)	(1,141,372)
Accumulated deficit	(36,070,416)	(38,275,076)
Total stockholders’ equity	8,489,608	6,237,200
Total liabilities and stockholders’ equity	$ 12,254,829	$ 19,581,021